Edition:
United States

West Pharmaceutical Services Inc (WST.N)

WST.N on New York Stock Exchange

85.15USD
18 Aug 2017
Change (% chg)

$-0.16 (-0.19%)
Prev Close
$85.31
Open
$85.33
Day's High
$85.43
Day's Low
$84.68
Volume
56,056
Avg. Vol
96,183
52-wk High
$99.87
52-wk Low
$70.19

Latest Key Developments (Source: Significant Developments)

West Pharmaceutical reports Q2 EPS $0.51
Thursday, 27 Jul 2017 06:00am EDT 

July 27 (Reuters) - West Pharmaceutical Services Inc :West announces second-quarter 2017 results.Sees fy 2017 adjusted earnings per share $2.66 to $2.73.Q2 adjusted earnings per share $0.66.Q2 earnings per share $0.51.Q2 sales $397.6 million versus I/B/E/S view $406 million.Sees FY 2017 sales $1.585 billion to $1.6 billion.Q2 earnings per share view $0.65 -- Thomson Reuters I/B/E/S.Revising full-year 2017 sales and adjusted-diluted EPS guidance.Full-year 2017 sales guidance is expected to be in a range between $1.585 billion and $1.600 billion.Sees FY 2017 consolidated gross profit margin (Pct of net sales) 32.7 pct to 33.3 pct.Sees 2017 capital spending to be up to $150 million, compared to a prior guidance range between $150 million and $175 million.FY2017 earnings per share view $2.73, revenue view $1.61 billion -- Thomson Reuters I/B/E/S.  Full Article

West Pharmaceutical announces increase to quarterly dividend
Thursday, 20 Jul 2017 06:00am EDT 

July 20 (Reuters) - West Pharmaceutical Services Inc :Sets quarterly dividend of $0.14 per share.West Pharmaceutical Services Inc - Q4 dividend of $0.14 per share, a 7.7 percent increase over $0.13 per share declared for each of four preceding quarters.  Full Article

West Pharmaceutical Q1 EPS $0.81
Thursday, 27 Apr 2017 07:00am EDT 

April 27 (Reuters) - West Pharmaceutical Services Inc :West announces first-quarter 2017 results.Q1 sales rose 7.1 percent to $387.7 million.Sees fy 2017 earnings per share $2.66 to $2.78.Q1 earnings per share $0.81.Sees fy 2017 sales $1.585 billion to $1.61 billion.West pharmaceutical services inc - reaffirming full-year 2017 sales and raising reported-diluted eps guidance.Fy2017 revenue view $1.60 billion -- Thomson Reuters I/B/E/S.Q1 revenue view $380.4 million -- Thomson Reuters I/B/E/S.  Full Article

West Pharmaceutical Services reports Q4 EPS $0.52
Thursday, 16 Feb 2017 07:00am EST 

West Pharmaceutical Services Inc - : Announces fourth-quarter and full-year 2016 results and announces quarterly dividend . Q4 earnings per share $0.52 . Q4 sales $382.3 million versus I/B/E/S view $387.3 million . Q4 earnings per share view $0.56 -- Thomson Reuters I/B/E/S . Sees fy 2017 adjusted earnings per share $2.45 to $2.57 . Q4 adjusted earnings per share $0.54 excluding items . Raising guidance for full-year 2017 net sales at constant-currency growth to a range of 7 pct to 9 pct . Sees fy 2017 consolidated net sales $1,585 million to $1,610 million .Estimates its 2017 capital spending to be in range of $150 million to $175 million.  Full Article

West Pharma Q3 adj EPS $0.53; sees FY'16 adj EPS $2.17-$2.22
Thursday, 27 Oct 2016 07:00am EDT 

West Pharmaceutical Services Inc : West announces third quarter 2016 results . Sees fy 2016 adjusted earnings per share $2.17 to $2.22 . Q3 adjusted earnings per share $0.53 . Q3 earnings per share $0.50 . Q3 sales $376.7 million versus i/b/e/s view $371.3 million . Q3 earnings per share view $0.53 -- Thomson Reuters I/B/E/S . Sees fy 2016 sales $1.51 billion to $1.52 billion . West pharmaceutical services inc- raising full-year 2016 net sales guidance and tightening adjusted diluted eps guidance range . West pharmaceutical services inc- full-year 2016 adjusted diluted EPS is now expected to be between $2.17 and $2.22 . West pharmaceutical services inc- company expects 2017 organic sales growth to grow at high end of its long-term outlook of 6% to 8% . West pharmaceutical services inc- sales growth of high-value products is expected to be in low-double digits for fy 2017 . West pharmaceutical- s reaffirming its 2020 financial targets of sales between $2.2 billion-$2.4 billion with a consolidated operating profit margin in range 19%-23% . Fy2016 earnings per share view $2.21 -- Thomson Reuters I/B/E/S . Fy2016 revenue view $1.51 billion -- Thomson Reuters I/B/E/S .Fy2017 revenue view $1.63 billion -- Thomson Reuters I/B/E/S.  Full Article

West Pharmaceutical Q2 earnings per share $0.60
Thursday, 28 Jul 2016 07:00am EDT 

West Pharmaceutical Services Inc Says Raising Our Full : Year 2016 organic sales growth guidance to a new range of between 7% and 9% . West announces second quarter 2016 results . Sees fy 2016 adjusted earnings per share $2.15 to $2.25 . Q2 adjusted earnings per share $0.59 excluding items . Q2 earnings per share $0.60 . Q2 sales $388 million versus i/b/e/s view $384.6 million . Sees fy 2016 sales $1.505 billion to $1.52 billion . Q2 earnings per share view $0.56 -- Thomson Reuters I/B/E/S . Fy2016 earnings per share view $2.21, revenue view $1.50 billion -- Thomson Reuters I/B/E/S .West pharmaceutical services inc says company estimates its 2016 capital spending at between $150 million and $175 million.  Full Article

West Pharmaceutical Services Inc announces quarterly dividend
Friday, 4 Mar 2016 07:00am EST 

West Pharmaceutical Services Inc:Board of Directors has approved a second-quarter 2016 dividend of $0.12 per share.Dividend will be paid on May 4 to shareholders of record date as of April 20.  Full Article

West Pharmaceutical Services Inc reaffirms FY 2016 guidance
Thursday, 18 Feb 2016 07:00am EST 

West Pharmaceutical Services Inc:FY 2016 net sales at constant currency to grow in the range of 6 pct. to 8 pct.Expects FY 2016 adjusted diluted EPS in the range of $2.10 to $2.25.  Full Article

West Pharmaceutical Services Inc announces quarterly dividend and share repurchase program
Thursday, 17 Dec 2015 08:00am EST 

West Pharmaceutical Services Inc:Approved a first-quarter 2016 dividend of $0.12 per share.Dividend will be paid on February 3, 2016 to shareholders of record as of January 20, 2016.Announced a share repurchase program authorizing the repurchase of up to 700,000 shares of the Company's common stock.  Full Article

West Pharmaceutical Services Inc updates FY 2015 guidance; gives FY 2016 revenue guidance
Thursday, 29 Oct 2015 07:00am EDT 

West Pharmaceutical Services Inc:Says that it expect a solid fourth quarter and to finish the year in the upper end of its prior guidance range for adjusted diluted EPS, and are raising the lower end of that range accordingly.Estimates FY 2015 net sales at constant currency will be in the lower end of the company's 7 pct. to 8 pct. guidance range.Expects FY 2016 net sales at constant currency to grow in the range of 6 pct. to 8 pct.  Full Article